Patricia C. Ledford

The Effects of Tegaserod (HTF 919) on the Pharmacokinetics and Pharmacodynamics of Digoxin in Healthy Subjects

Honghui Zhou, M. Hubert, J. McLeod, 2001, Journal of clinical pharmacology.

Tegaserod does not significantly affect the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

N. On, S. Osborne, J. Campestrini, 2000 .